Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Breast Neoplasms 379Neoplasms 336Carcinoma, Non-Small-Cell Lung 297Prostatic Neoplasms 250Colorectal Neoplasms 223Lung Neoplasms 195Multiple Myeloma 155Ovarian Neoplasms 142Pancreatic Neoplasms 140Neoplasm Metastasis 132Leukemia, Myeloid, Acute 129Melanoma 112Squamous Cell Carcinoma of Head and Neck 96Lymphoma 89Carcinoma, Renal Cell 89Stomach Neoplasms 87Recurrence 87Lymphoma, Non-Hodgkin 86Endometrial Neoplasms 85Brain Neoplasms 83Carcinoma, Hepatocellular 82Precursor Cell Lymphoblastic Leukemia-Lymphoma 81Head and Neck Neoplasms 73Glioma 73Glioblastoma 73Uterine Cervical Neoplasms 71Sarcoma 69Urinary Bladder Neoplasms 67Hematologic Neoplasms 66Leukemia, Lymphocytic, Chronic, B-Cell 65

Interventions

pembrolizumab 1epacadostat 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Immunoglobulin G 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Extensive Stage Small Cell Lung Carcinoma × 30 days × Clear all
NCT03402880 2026-05-29

ALCMI-005: Pembrolizumab and Epacadostat in Treating Patients With Extensive Stage Small Cell Lung Cancer

City of Hope Medical Center

Phase 2 Withdrawn
Thoracic

Extensive Stage Small Cell Lung Carcinoma

NCT02635009 2026-05-19

Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Limited Stage or Extensive Stage Small Cell Lung Cancer

NRG Oncology

Phase 2/3 Completed
418 enrolled 52 charts
Thoracic

Extensive Stage Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡